GENE ONLINE|News &
Opinion
Blog

2021-01-24| ChinaCOVID-19

Expecting Lunar New Year Travel Rush, China Races to Build Giant Quarantine Center

by Tyler Chen
Share To

Outside Shijiazhuang, Hebei province, over 4,000 construction workers are building a giant quarantine center of 4,156 units that can house COVID-19 patients within days of diagnosis.

 

New Wave of COVID-19 Cases

According to WHO’s data, China has 99,414 confirmed cases of COVID-19 with 4,808 deaths as of January 21st. As the Lunar New Year approaches, China expects a new wave of COVID-19 cases where city residents are traveling across the country to meet their families. To alleviate the burden on the healthcare system, China has started constructing a new quarantine location on January 13th on the outskirts of Northern China.

 

Quarantine Unit

Each unit in the quarantine center is equipped with basic facilities, including internet, bathroom, bedroom, air conditioning, etc. District 1 is currently moving to the last phase. Most of the infrastructures are done with air conditioning and water heaters waiting to be installed. Within days, China has successfully delivered 606 units and is estimated to reach 1,779 in total by the end of January.

 

Individual Testing of COVID-19

Furthermore, China has scheduled to perform a COVID-19 testing plan in the quarantine center for each individual. Every personnel and quarantine related parties will undergo a nucleic acid amplification testing (NAAT) for COVID-19 from January 20 to 22nd, and there will be 28 testing companies for professional and efficient screening.

Related Article: COVID-19: South Korea and Japan Make New Plans to Fight the Pandemic

References
  1. http://www.gov.cn/xinwen/2021-01/19/content_5581124.htm#1
  2. http://www.sjz.gov.cn/col/1609405465981/2021/01/21/1611190892875.html
  3. http://www.sjz.gov.cn/col/1596014213243/2021/01/20/1611105496040.html
  4. https://www.163.com/dy/article/G0SLI3JB0514R9KE.html

 

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
Sanofi, GSK Secure European COVID-19 Booster Approval, AstraZeneca Withdraws U.S. Application
2022-11-10
LATEST
Rebyota Passes Through FDA To Become First Approved Fecal Microbiota Product
2022-12-05
RemeGen Presented New Data Updates on Telitacicept for SLE and primary Sjogren’s syndrome at ACR Convergence 2022
2022-12-05
EMA Urges Pholcodine’s Removal from European Market Following Safety Study
2022-12-05
Lynk Pharmaceuticals Announces First Patient Dosed in Phase Ⅱ Clinical Study of LNK01003 in Patients with Ulcerative Colitis
2022-12-04
Cure Brain Cancer Foundation Rings Nasdaq Opening Bell, Announces U.S. Expansion
2022-12-02
Focus-X Therapeutics, a Viva Biotech Portfolio Company, Successfully Reached an Acquisition Agreement with Full-Life Technologies
2022-12-02
Pfizer To Invest $1.26 Billion In Irish Plant, Forms New Vant Company Targeting Inflammation
2022-12-02
EVENT
2022-12-10
64TH ASH ANNUAL MEETING & EXPOSITION
New Orleans, USA
2022-12-14
BIOHK2022
Hong Kong, China
2022-12-21
Avatar Medicine Forum
Online
2023-01-07
7th Asia Microbiome Conference
Taipei, Taiwan
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!